{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001039408.1:c.6056G>A",
          "cDNA Change": {
            "transcript": "NM_001039408.1",
            "ref": "G",
            "alt": "A",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S variant linked to familial Parkinson's disease"
        },
        {
          "HGVS": "NM_001039408.1:c.4322G>T",
          "cDNA Change": {
            "transcript": "NM_001039408.1",
            "ref": "G",
            "alt": "T",
            "position": "4322"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C variant associated with Parkinson's disease"
        },
        {
          "HGVS": "NM_001039408.1:c.4322G>G",
          "cDNA Change": {
            "transcript": "NM_001039408.1",
            "ref": "G",
            "alt": "G",
            "position": "4322"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "G",
            "position": "1441"
          },
          "Description in input context": "R1441G variant linked to Parkinson's disease"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005123"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with LRRK2 variants and wild-type constructs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001039408.1:c.6056G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased phosphorylation of LRRK2 at S1292 in G2019S-expressing cells compared to wild-type."
        },
        {
          "Variant": "NM_001039408.1:c.4322G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Enhanced kinase activity in R1441C-expressing cells."
        },
        {
          "Variant": "NM_001039408.1:c.4322G>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "R1441G variant showed higher phosphorylation levels than wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation levels within 15% of wild-type control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels exceeding 30% of wild-type control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Kinase Activity Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "SH-SY5Y cells overexpressing LRRK2 variants were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001039408.1:c.6056G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "G2019S-expressing cells showed 2.5-fold higher kinase activity than wild-type."
        },
        {
          "Variant": "NM_001039408.1:c.4322G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "R1441C-expressing cells exhibited 1.8-fold increased kinase activity."
        },
        {
          "Variant": "NM_001039408.1:c.4322G>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "R1441G-expressing cells showed 1.4-fold higher kinase activity."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 20% of wild-type control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity exceeding 40% of wild-type control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunofluorescence",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with LRRK2 variants and stained for autophagy markers."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001039408.1:c.6056G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "G2019S-expressing cells showed 30% reduction in LC3B puncta compared to wild-type."
        },
        {
          "Variant": "NM_001039408.1:c.4322G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "R1441C-expressing cells exhibited 25% reduction in LC3B puncta."
        },
        {
          "Variant": "NM_001039408.1:c.4322G>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "R1441G-expressing cells showed 20% reduction in LC3B puncta."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "LC3B puncta levels within 10% of wild-type control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "LC3B puncta levels below 30% of wild-type control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cell Viability Assay",
      "Material used": {
        "Material Source": "Primary cells",
        "Material Name": "Patient-derived fibroblasts",
        "Description": "Fibroblasts from Parkinson's disease patients were treated with LRRK2 inhibitors."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001039408.1:c.6056G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "G2019S-expressing fibroblasts showed 20% lower viability after inhibitor treatment."
        },
        {
          "Variant": "NM_001039408.1:c.4322G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "R1441C-expressing fibroblasts exhibited 15% lower viability."
        },
        {
          "Variant": "NM_001039408.1:c.4322G>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "R1441G-expressing fibroblasts showed 10% lower viability."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type fibroblasts were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untreated fibroblasts were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability within 5% of wild-type control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cell viability below 15% of wild-type control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}